secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dogwood Therapeutics, Inc. (DWTX)
CIK:        0001818844
Form:       8-K
Filed at:   2023-06-20T23:59:59+00:00
Accession:  0001558370-23-011237
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Virios shareholders reject proposed reverse stock split at annual meeting
-------------------------------------------------------------------------

- Reverse stock split proposal (1:2 to 1:25) failed: 9,011,430 for, 720,787 against, 123,006 abstain.
- Split required majority of outstanding shares (~9.17M); for votes were 9,011,430, short of threshold.
- Board had proposed split to regain Nasdaq compliance amid low stock price.
- All seven director nominees elected with 4.05M-5.40M for votes; auditor FORVIS ratified.
- Quorum of 9,855,223 shares (53.76% of outstanding) present at June 15, 2023 meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818844/000155837023011237/0001558370-23-011237-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818844/000155837023011237/tmb-20230615x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-011237

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer